We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current GNPX market cap is 3.31M. The company's latest EPS is USD -20.7690 and P/E is -0.11.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6.11M | -6.82M | -9.27M | -8.04M | -7.78M |
| Net Income | -6.08M | -6.77M | -9.2M | -7.98M | -7.75M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -10.68M | -17.96M | -19.6M | -23.83M | -31.08M |
| Net Income | -10.66M | -17.94M | -19.6M | -23.74M | -30.86M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 29.95M | 25.09M | 23.32M | 15.91M | 16.64M |
| Total Liabilities | 2.46M | 2.81M | 4.84M | 3.86M | 4.34M |
| Total Equity | 27.49M | 22.28M | 18.49M | 12.05M | 12.31M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.53M | 31.37M | 42.86M | 25.09M | 10.67M |
| Total Liabilities | 510k | 451k | 1.59M | 2.81M | 3.26M |
| Total Equity | 3.02M | 30.92M | 41.28M | 22.28M | 7.42M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -13.19M | -17.78M | -6.93M | -15.04M | -19.78M |
| Investing | 78k | 97k | -20k | -40k | -61k |
| Financing | 2k | 7k | 4.08M | 4.08M | 10.59M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.92M | -13.94M | -14.29M | -17.78M | -24.74M |
| Investing | -947k | -2.34M | -84k | 97k | -71k |
| Financing | 1.27M | 41.59M | 25.68M | 7k | 10.59M |
| Market Cap | 3.31M |
| Price to Earnings Ratio | -0.11 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.49 |
| Price to Book Ratio | 0.45 |
| Dividend Yield | - |
| Shares Outstanding | 1.49M |
| Average Volume (1 week) | 17.19k |
| Average Volume (1 Month) | 33.71k |
| 52 Week Change | -93.04% |
| 52 Week High | 42.40 |
| 52 Week Low | 2.09 |
| Spread (Intraday) | 0.07 (3.06%) |
| Company Name | Genprex Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.genprex.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
